Literature DB >> 11717387

Stimulation of endorphin neurotransmission in the nucleus accumbens by ethanol, cocaine, and amphetamine.

M F Olive1, H N Koenig, M A Nannini, C W Hodge.   

Abstract

Numerous studies have demonstrated that drugs of abuse activate the mesolimbic dopamine reward pathway, and it is widely held that this activation contributes to the motivational and positive reinforcing properties of these substances. However, there is evidence that endogenous opioid systems within this brain reward circuit also play a role in drug reinforcement and drug-seeking behavior. Using microdialysis in freely moving rats, we sought to determine whether various drugs of abuse (i.e., ethanol, cocaine, d-amphetamine, and nicotine) would increase neurotransmission of endogenous opioid peptides (i.e., endorphins) in the nucleus accumbens. Drugs were administered intraperitoneally twice at 3 h intervals, and the endorphin content of microdialysates was analyzed by a solid-phase radioimmunoassay. Acute administration of ethanol, cocaine, and d-amphetamine transiently elevated extracellular levels of endorphins in the nucleus accumbens, whereas nicotine and saline were without effect. We hypothesize that this drug-induced release of endorphins may contribute to the positive reinforcing and motivating properties of ethanol and psychostimulants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11717387      PMCID: PMC6763912     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  109 in total

1.  Dopaminergic reward system: a short integrative review.

Authors:  Oscar Arias-Carrión; Maria Stamelou; Eric Murillo-Rodríguez; Manuel Menéndez-González; Ernst Pöppel
Journal:  Int Arch Med       Date:  2010-10-06

2.  Sex differences in the effects of adolescent social deprivation on alcohol consumption in μ-opioid receptor knockout mice.

Authors:  Yuki Moriya; Yoshiyuki Kasahara; F Scott Hall; Yasufumi Sakakibara; George R Uhl; Hiroaki Tomita; Ichiro Sora
Journal:  Psychopharmacology (Berl)       Date:  2014-11-04       Impact factor: 4.530

Review 3.  Microdialysis as a tool in local pharmacodynamics.

Authors:  Yanjun Li; Joanna Peris; Li Zhong; Hartmut Derendorf
Journal:  AAPS J       Date:  2006-04-07       Impact factor: 4.009

Review 4.  Neurochemical and neurostructural plasticity in alcoholism.

Authors:  Justin T Gass; M Foster Olive
Journal:  ACS Chem Neurosci       Date:  2012-04-16       Impact factor: 4.418

5.  Involvement of the beta-endorphin neurons of the hypothalamic arcuate nucleus in ethanol-induced place preference conditioning in mice.

Authors:  Raúl Pastor; Laura Font; Marta Miquel; Tamara J Phillips; Carlos M G Aragon
Journal:  Alcohol Clin Exp Res       Date:  2011-10-20       Impact factor: 3.455

6.  Attenuated beta endorphin response to acute stress is associated with smoking relapse.

Authors:  Darcy Shaw; Mustafa al'Absi
Journal:  Pharmacol Biochem Behav       Date:  2008-04-03       Impact factor: 3.533

7.  Effects of acute ethanol on beta-endorphin release in the nucleus accumbens of selectively bred lines of alcohol-preferring AA and alcohol-avoiding ANA rats.

Authors:  Minh P Lam; Harri Nurmi; Noora Rouvinen; Kalervo Kiianmaa; Christina Gianoulakis
Journal:  Psychopharmacology (Berl)       Date:  2009-11-26       Impact factor: 4.530

Review 8.  Microdialysis and the neurochemistry of addiction.

Authors:  Mary M Torregrossa; Peter W Kalivas
Journal:  Pharmacol Biochem Behav       Date:  2007-09-12       Impact factor: 3.533

9.  Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.

Authors:  Sarah Sushchyk; Zheng-Xiong Xi; Jia Bei Wang
Journal:  J Pharmacol Exp Ther       Date:  2016-02-22       Impact factor: 4.030

10.  Motor stimulant effects of ethanol and acetaldehyde injected into the posterior ventral tegmental area of rats: role of opioid receptors.

Authors:  María José Sánchez-Catalán; Lucía Hipólito; Teodoro Zornoza; Ana Polache; Luis Granero
Journal:  Psychopharmacology (Berl)       Date:  2009-02-24       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.